Barley Grass Research: Comparing What Each Study Type ShowsBarley grass research spans uncontrolled human diet studies, narrative reviews, in vitro cell work, and unrelated soil-chemistr...
Inside 2026's FDA Supplement Recalls: What the Records ShowA review of 2026 FDA dietary supplement enforcement reports—spanning contamination, undeclared allergens, mislabeled ingredient...
Barberry and Glucose Metabolism: What Human Studies ShowAn evidence-focused review of barberry (Berberis species) research, separating small human trials from animal and mechanistic s...
Cold Season Trials: Why Immune Research Is Getting RigorousA newly registered trial testing an immune ingredient against common cold incidence reflects a broader shift toward outcome-bas...
Bamboo Extract Evidence Review: What the Research Actually ShowsThis review examines the published "bamboo" medical literature and finds it dominated by an unrelated clinical term—bamboo node...
Astragalus Evidence Review: What Human Research ShowsAstragalus research spans mechanistic cell studies, rodent tumor models, and narrative reviews, with immune-signaling and polys...
How to Evaluate Astaxanthin Research: A Reader's GuideA guide to reading astaxanthin research the way a reviewer would: sorting animal data from human trials, spotting formulation d...
Ashwagandha: Stress Evidence vs. Sleep Evidence ComparedAshwagandha research splits into two overlapping but distinct outcome categories: perceived stress/anxiety-related measures and...
FDA Recall Signals: Moringa Salmonella Risk in ContextA 2026 Class I recall of moringa capsules over possible Salmonella contamination sits alongside a dozen other FDA enforcement r...
Sports Nutrition Tools Move Into Childbirth ResearchA newly registered pilot trial testing carbohydrate gels against electrolyte drinks during labor reflects a broader pattern: re...
Beet Root Research: Blood Pressure vs. Exercise Outcomes ComparedBeet root research spans two distinct outcome categories: acute blood-pressure and vascular measures, and exercise-efficiency m...
FDA Recall Signal: One Class II Report in Sector ContextA June 2026 FDA Class II recall of a multi-ingredient gut-health supplement, cited for premature lipid oxidation, is examined a...